Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Nov 16, 2010

Premium

Foundation Medicine has appointed Maureen Cronin as its senior vice president of research and product development.

Cronin joins Foundation from Genomic Health, where she most recently served as vice president of translational research. Prior to Genomic Health, Cronin was senior director of applied genomics at Aclara Biosciences. She also worked at Affymetrix, where she managed contract research programs focused on developing assays for partners that included Hewlett Packard, Roche, and GlaxoWellcome.

Cronin holds a PhD in physiology and pharmacology from the University of California, San Diego.


John Bellano has resigned from his position as senior vice president of commercial operations at GenMark Diagnostics, the company said in a filing with the US Securities and Exchange Commission last week.

Bellano's responsibilities will be divided among Jennifer Williams, who has been promoted to senior VP of global operations; Jeff Hawkins, who has been promoted to senior VP of marketing and business development; and Mike Gleeson, who has been promoted to VP of US sales.


Tecan last week named Frederic Vanderhaegen to head its Life Sciences business. Vanderhaegen previously worked in management and sales at Millipore.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.